PUBLIC COMPANY
save$FDMT4D Molecular Therapeutics, Inc.
$FDMTEmeryville, CA, USupdated 3mo ago
community read0 votes
pipeline
3
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(3)
pipeline depth3 products
2Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
- phase3Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- phase34D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- phase24D-710 in Adult Patients With Cystic Fibrosis
- phase24D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- phase24D-150 in Patients With Diabetic Macular Edema
- phase1Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia
- phase24D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP)
🐶 Hiring Signal
News
- BioSpace 2027 Best Places to Work shines light on most admired employersThe list honors 50 life sciences employers of choice. Employees at SERB Pharmaceuticals and CSL Behring share why their companies stand out.biospace · 7d ago
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that